CAIM
TMO icon

Catherine Avery Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Catherine Avery Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.02K Hold
12
– – ﹤0.01% 132
2026
Q1 		$5.9K Hold
12
– – ﹤0.01% 96
2025
Q4 		$6.95K Hold
12
– – ﹤0.01% 108
2025
Q3 		$5.82K Hold
12
– – ﹤0.01% 116
2025
Q2 		$4.87K Hold
12
– – ﹤0.01% 121
2025
Q1 		$5.97K Hold
12
– – 0.01% 112
2024
Q4 		$6.24K Buy
+12
New +$6.6K 0.01% 107

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Catherine Avery Investment Management's TMO Position: Q2 2026 in Review

Catherine Avery Investment Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 12 shares worth $6.02K. The position accounts for ﹤0.01% of the portfolio, ranked #132.

Catherine Avery Investment Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.95K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Catherine Avery Investment Management held 12 shares of Thermo Fisher Scientific worth $6.02K as of Q2 2026.
  • Catherine Avery Investment Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of Catherine Avery Investment Management's portfolio in Q2 2026, its #132 holding.
  • Catherine Avery Investment Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Catherine Avery Investment Management's Thermo Fisher Scientific position peaked at $6.95K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Catherine Avery Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.